Real-world data on change in work productivity, activity impairment, and quality of life in patients with psoriatic arthritis under anti-TNF therapy: a postmarketing, noninterventional, observational study

---

Copy For Citation

KARADAĞ Ö., DALKILIÇ H. E., AYAN G., KÜÇÜKŞAHİN O., KAŞİFOĞLU T., Yilmaz N., ...More

CLINICAL RHEUMATOLOGY, vol.41, no.1, pp.85-94, 2022 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 41 Issue: 1
• Publication Date: 2022
• Doi Number: 10.1007/s10067-021-05893-3
• Journal Name: CLINICAL RHEUMATOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
• Page Numbers: pp.85-94
• Keywords: Anti-TNF, ACR20/50/70, DAPSA28, DAS28, Psoriatic arthritis, Work disability, CERTOLIZUMAB PEGOL, CLINICAL-RESPONSE, DISEASE-ACTIVITY, DOUBLE-BLIND, PHASE-III, GOLIMUMAB, SAFETY, TRIAL, MULTICENTER, ETANERCEPT
• Hacettepe University Affiliated: Yes

Abstract

Objectives To understand change in work productivity, activity impairment, quality of life (QoL), and disease activity in patients with psoriatic arthritis (PsA) receiving anti-tumor necrosis factor (anti-TNF) treatment.